Likewise, other pro-inflammatory cytokines such as IL-6, IL-1, and TNF-α also can drive stem-cell like transition via EMT pathway in high-grade gliomas, leading to GSC-related tumor progression and therapy resistance. Here, IL1B is linked to neoplasm.